Literature DB >> 1384677

Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma.

S L Speaks1, W G Sanger, A S Masih, D S Harrington, M Hess, J O Armitage.   

Abstract

Many nonrandom chromosome abnormalities have been associated with non-Hodgkin's lymphomas (NHL). Some of these are nonspecific changes seen in many different histologic subtypes. We describe a series of abnormalities of chromosome bands 10q23-25 seen in 159 consecutive NHL patients with abnormal cytogenetic findings. The proportion of karyotypes with abnormalities of 10q varied from 3% among the immunoblastic lymphomas to 67% in the diffuse large cleaved cell lymphomas. Seventeen (10.7%) had abnormalities of 10q23-25. All but one of these were B-cell tumors. The abnormalities consisted of six deletions and 11 translocations. Sixteen of the 17 patients had the 10q abnormality when cells were first karyotyped. The remaining patient acquired the 10q abnormality in the third of a series of biopsies. In the follicular histologic subtypes [follicular small cleaved cell (FSC), follicular mixed small cleaved and large cell (FM), and follicular large cell noncleaved (FL-NC)], abnormalities of 10q were found in nine patients, all in association with abnormalities of 14q32. Seven of these were associated with the t(14;18)(q32;q21). Overall, 10q23-25 abnormalities were observed in 11.9% (8/67) of low-grade [small lymphocytic (SL), FSC, and FM] lymphoma cases. DNA was available from five patients with abnormalities of 10q and was probed for rearrangements with the HOXII (TCL3) oncogene probe. As expected, we did not find such rearrangements in these five patients with B-cell tumors. Abnormalities of 10q23-25 have been reported previously in NHL but not at this frequency.

Entities:  

Mesh:

Year:  1992        PMID: 1384677     DOI: 10.1002/gcc.2870050311

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjögren's syndrome.

Authors:  A M Raizis; M M Ferguson; B A Robinson; C H Atkinson; P M George
Journal:  Mol Pathol       Date:  1998-12

2.  Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q.

Authors:  R Albarosa; B M Colombo; L Roz; I Magnani; B Pollo; N Cirenei; C Giani; A M Conti; S DiDonato; G Finocchiaro
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

3.  A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice.

Authors:  S L Peng; M E Robert; A C Hayday; J Craft
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

4.  Refined physical map of the human PAX2/HOX11/NFKB2 cancer gene region at 10q24 and relocalization of the HPV6AI1 viral integration site to 14q13.3-q21.1.

Authors:  Sheryl M Gough; Margaret McDonald; Xiao-Ning Chen; Julie R Korenberg; Antonino Neri; Tomas Kahn; Michael R Eccles; Christine M Morris
Journal:  BMC Genomics       Date:  2003-03-03       Impact factor: 3.969

5.  PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.

Authors:  Y Fujiwara; D S Hoon; T Yamada; K Umeshita; M Gotoh; M Sakon; I Nishisho; M Monden
Journal:  Jpn J Cancer Res       Date:  2000-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.